SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001104659-23-125421
Filing Date
2023-12-12
Accepted
2023-12-12 17:15:51
Documents
7
Group Members
ISOCHRONE MERGER SUB INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-C tm2332587d2_sctoc.htm SC TO-C 26484
2 EXHIBIT 99.1 tm2332587d2_ex99-1.htm EX-99.1 31661
3 EXHIBIT 99.2 tm2332587d2_ex99-2.htm EX-99.2 5217
4 EXHIBIT 99.3 tm2332587d2_ex99-3.htm EX-99.3 6268
5 EXHIBIT 99.4 tm2332587d2_ex99-4.htm EX-99.4 6388
6 EXHIBIT 99.5 tm2332587d2_ex99-5.htm EX-99.5 4199
7 GRAPHIC tm2332587d2_ex99-2img001.jpg GRAPHIC 8253
  Complete submission text file 0001104659-23-125421.txt   93499
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Subject) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-92771 | Film No.: 231482058
SIC: 2836 Biological Products, (No Diagnostic Substances)